Trend Structure
Price sits below both the 50- and 200-day moving averages. Rallies in this configuration tend to be sold; the burden of proof is on the bulls.
←Back to list
JSE ticker · ISO
ASP ISOTOPES INC. (ISO) Share Price & Latest SENS Announcements
ASP Isotopes Inc.
Basic Materials · Specialty Chemicals
Track ASP Isotopes Inc. (ISO) share price moves, recent SENS announcements, company profile details, and Basic Materials sector, specialty chemicals, all in one place.
R 52,00
▼ 0,99 / -1.87%
LIVE · 12:07 SAST
MOMENTUM · DOWN
Latest SENS Announcements — ASP ISOTOPES INC. (ISO)
10 most recent- 11 Sep Director Dealings
ASP ISOTOPES INC - Form 4 statement of changes in beneficial ownership
Form 4 filed with the SEC, but this SENS announcement discloses no transaction details whatsoever.
NEUTRAL 0 - 10 Sep Regulatory Filing
ASP ISOTOPES INC - Rule 425 written communication related to a business combination and Form 425 - prospectuses and communications, business combinations
ASPI confirms SEC filings related to a previously-disclosed business combination; no new terms disclosed.
NEUTRAL 0 - 08 Sep Other Administrative
ASP ISOTOPES INC - Form 8-K Current report
ASPI flags a filed SEC Form 8-K via SENS link; the SENS notice reproduces no 8-K content.
NEUTRAL 0 - 08 Sep Operational Update
ASP ISOTOPES INC - ASPI hosts inaugural capital markets day and provides operational update
ASPI's inaugural Capital Markets Day is an investor presentation event; this notice contains no new financial figures or updated guidance.
NEUTRAL 0 - 07 Sep Director Dealings
ASP ISOTOPES INC - Form 4 statement of changes in beneficial ownership
Three Form 4s filed with the SEC; the SENS text discloses nothing about the actual transactions.
NEUTRAL 0 - 03 Sep Director Dealings
ASP ISOTOPES INC - Form 144 Report of Proposed Sale of Securities
Form 144 proposed-sale notices filed with the SEC; SENS summary gives no sale terms.
NEUTRAL 0 - 21 Aug Regulatory Filing
ASP ISOTOPES INC - Form 425 - Prospectuses and Communications, Business Combinations
ASPI files Form 425 with the SEC; the substantive content lives in a linked document the SENS notice does not reproduce.
NEUTRAL 0 - 21 Aug Other Administrative
ASP ISOTOPES INC - Form 8-K Current Report
SENS notice flags an SEC 8-K filing; the actual 8-K content is not reproduced here, so nothing new to act on.
NEUTRAL 0 - 20 Aug Other Administrative
ASP ISOTOPES INC - Form 8-K Current Report and Rule 425 Written Communication Related to a Business Combination
ASPI confirms it filed 8-K and Rule 425 documents for a business combination, but the SENS release discloses no deal terms, target, or financial detail.
NEUTRAL 0 - 20 Aug Operational Update
ASP ISOTOPES INC - ASPI announces that Renergen Limiteds subsidiary has commenced commissioning of liquid helium plant in South Africa
Virginia Gas Phase 1 helium commissioning underway; September deliveries on track, but Phase 2 funding is non-binding and 85% of helium uncontracted.
NEUTRAL 0
Valuation
—
Growth
Deteriorating
Momentum
Bearish
Volume
Normal
SENS Signal
Mixed
Price · Close
- Trend
- Down · below 50 & 200
- Momentum
- Down
- RSI 14
- 35
- 30D Vol
- 61.3%
52W Range
R 50
R 300
Current: R 52(1% through range)
What Changed
Delta view Today
-1.87%
5 days
+1.60%
30 days
-27.17%
90 days
-46.04%
Year-to-date
-46.67%
vs 50-day MA
-19.53%
vs 200-day MA
-43.22%
Latest SENS 11d ago: "ASP ISOTOPES INC - Form 4 statement of changes in beneficial ownership" — reading mixed.
Market
Market Cap
R 8.0B
52W High
300.00
52W Low
50.00
52W Pos.
1%
Avg Vol 30D
44.0K
Valuation
P/E (TTM)
— check source
Fwd EPS
—
Fwd P/E
—
Div Yield
—
Technicals
Annualised · 30 sessions RSI 14
35.0
MA 50
64.62 ▼
MA 200
91.59 ▼
30-Session Vol
61.3%
Analyst ratings & fundamentals for ASP ISOTOPES INC. aren't available yet.
Why It Matters
Combined view About ASP Isotopes Inc.
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.
- Exchange
- Johannesburg
- Currency
- ZAc
- Employees
- 271
- Country
- United States
- Website
- https://aspisotopes.com
Related
Build your JSE watchlist.
Save tickers, follow new SENS announcements, and get personalised daily analysis.
→ Create Free Account